带状疱疹疫苗接种意向量表的制定和社区卫生中心中老年参与者疫苗犹豫相关因素的确定:基于保护动机理论的研究

IF 3.5 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Human Vaccines & Immunotherapeutics Pub Date : 2025-12-01 Epub Date: 2025-06-16 DOI:10.1080/21645515.2025.2516947
Ying Gao, Ting Wei, Ruijie Gong, Linfei Cai, Yuhui Sheng, Meili Shang, Yang Ni
{"title":"带状疱疹疫苗接种意向量表的制定和社区卫生中心中老年参与者疫苗犹豫相关因素的确定:基于保护动机理论的研究","authors":"Ying Gao, Ting Wei, Ruijie Gong, Linfei Cai, Yuhui Sheng, Meili Shang, Yang Ni","doi":"10.1080/21645515.2025.2516947","DOIUrl":null,"url":null,"abstract":"<p><p>A cross-sectional survey was conducted in Shanghai, China, from October to December 2022. Participants aged 40 years or older were recruited from seven community health centers (CHCs). Vaccine hesitancy was defined as participants who had neither received the HZ vaccine nor expressed intention to receive it. Data on socio-demographic characteristics, health behaviors and vaccine hesitancy were collected using a structured questionnaire. A PMT-based HZ vaccination intention scale consisting of five dimensions (Intrinsic Rewards, Extrinsic Rewards, Self-Efficacy, Response Efficacy, and Response Costs) was developed. Group comparisons between the vaccine hesitancy and non-hesitancy groups were made using the Mann-Whitney U test for continuous variables and the chi-square test for categorical variables. Logistic regression was used to identify factors associated with vaccine hesitancy, and a nomogram was constructed to summarize these associations. Receiver operating characteristic (ROC) analysis was performed to assess the degree of association between the PMT dimensions and vaccine hesitancy.</p><p><p>Among 1,492 participants (median age 53; 64.2% female), 80.5% of participants reported HZ vaccine hesitancy. Hesitancy was significantly associated with older age, peri-urban residence, employment and no history of HZ infection (<i>p</i> < .01). Among the PMT dimensions, lower Self-Efficacy (<i>p=</i>0.025), higher Response Costs (<i>p</i> < .001), and stronger Intrinsic Rewards (<i>p</i> = .002) and Extrinsic Rewards (<i>p</i> < .001) significantly contributed to hesitancy, while Response Efficacy (<i>p</i> = .230) showed no clear association. The adjusted multivariate logistic regression model had an area under the curve (AUC) of 0.788, with Self-Efficacy and Extrinsic Rewards showing notable individual contributions (AUC = 0.713 and 0.696, respectively).</p><p><p>HZ vaccine hesitancy is shaped by psychological and contextual factors. Public health strategies should prioritize perceived rewards, self-efficacy, and response costs. The tools developed in this study may guide targeted interventions in primary care. Future research should validate them across populations and assess their predictive utility in real-world settings.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2516947"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184168/pdf/","citationCount":"0","resultStr":"{\"title\":\"Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protection Motivation Theory based study.\",\"authors\":\"Ying Gao, Ting Wei, Ruijie Gong, Linfei Cai, Yuhui Sheng, Meili Shang, Yang Ni\",\"doi\":\"10.1080/21645515.2025.2516947\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A cross-sectional survey was conducted in Shanghai, China, from October to December 2022. Participants aged 40 years or older were recruited from seven community health centers (CHCs). Vaccine hesitancy was defined as participants who had neither received the HZ vaccine nor expressed intention to receive it. Data on socio-demographic characteristics, health behaviors and vaccine hesitancy were collected using a structured questionnaire. A PMT-based HZ vaccination intention scale consisting of five dimensions (Intrinsic Rewards, Extrinsic Rewards, Self-Efficacy, Response Efficacy, and Response Costs) was developed. Group comparisons between the vaccine hesitancy and non-hesitancy groups were made using the Mann-Whitney U test for continuous variables and the chi-square test for categorical variables. Logistic regression was used to identify factors associated with vaccine hesitancy, and a nomogram was constructed to summarize these associations. Receiver operating characteristic (ROC) analysis was performed to assess the degree of association between the PMT dimensions and vaccine hesitancy.</p><p><p>Among 1,492 participants (median age 53; 64.2% female), 80.5% of participants reported HZ vaccine hesitancy. Hesitancy was significantly associated with older age, peri-urban residence, employment and no history of HZ infection (<i>p</i> < .01). Among the PMT dimensions, lower Self-Efficacy (<i>p=</i>0.025), higher Response Costs (<i>p</i> < .001), and stronger Intrinsic Rewards (<i>p</i> = .002) and Extrinsic Rewards (<i>p</i> < .001) significantly contributed to hesitancy, while Response Efficacy (<i>p</i> = .230) showed no clear association. The adjusted multivariate logistic regression model had an area under the curve (AUC) of 0.788, with Self-Efficacy and Extrinsic Rewards showing notable individual contributions (AUC = 0.713 and 0.696, respectively).</p><p><p>HZ vaccine hesitancy is shaped by psychological and contextual factors. Public health strategies should prioritize perceived rewards, self-efficacy, and response costs. The tools developed in this study may guide targeted interventions in primary care. Future research should validate them across populations and assess their predictive utility in real-world settings.</p>\",\"PeriodicalId\":49067,\"journal\":{\"name\":\"Human Vaccines & Immunotherapeutics\",\"volume\":\"21 1\",\"pages\":\"2516947\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184168/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human Vaccines & Immunotherapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/21645515.2025.2516947\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2516947","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

一项横断面调查于2022年10月至12月在中国上海进行。年龄在40岁或以上的参与者从7个社区卫生中心(CHCs)招募。疫苗犹豫被定义为既没有接种过HZ疫苗也没有表示打算接种疫苗的参与者。使用结构化问卷收集社会人口特征、健康行为和疫苗犹豫的数据。建立了基于pmt的HZ疫苗接种意向量表,包括5个维度(内在奖励、外在奖励、自我效能、反应效能和反应成本)。疫苗犹豫组和非犹豫组之间的组间比较采用连续变量的Mann-Whitney U检验和分类变量的卡方检验。使用逻辑回归来确定与疫苗犹豫相关的因素,并构建nomogram来总结这些关联。采用受试者工作特征(ROC)分析评估PMT各维度与疫苗犹豫之间的关联程度。1492名参与者(中位年龄53岁;64.2%女性),80.5%的参与者报告了HZ疫苗犹豫。犹豫与年龄较大、近郊居住、就业和无HZ感染史显著相关(p =0.025),较高的反应成本(p = 0.002)和外在奖励(p = 0.230)无明显关联。调整后的多元logistic回归模型的曲线下面积(AUC)为0.788,自我效能和外在奖励的个体贡献显著(AUC分别为0.713和0.696)。HZ疫苗犹豫是由心理和环境因素决定的。公共卫生战略应优先考虑感知奖励、自我效能和反应成本。本研究开发的工具可以指导有针对性的初级保健干预措施。未来的研究应该在人群中验证它们,并评估它们在现实世界中的预测效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protection Motivation Theory based study.

A cross-sectional survey was conducted in Shanghai, China, from October to December 2022. Participants aged 40 years or older were recruited from seven community health centers (CHCs). Vaccine hesitancy was defined as participants who had neither received the HZ vaccine nor expressed intention to receive it. Data on socio-demographic characteristics, health behaviors and vaccine hesitancy were collected using a structured questionnaire. A PMT-based HZ vaccination intention scale consisting of five dimensions (Intrinsic Rewards, Extrinsic Rewards, Self-Efficacy, Response Efficacy, and Response Costs) was developed. Group comparisons between the vaccine hesitancy and non-hesitancy groups were made using the Mann-Whitney U test for continuous variables and the chi-square test for categorical variables. Logistic regression was used to identify factors associated with vaccine hesitancy, and a nomogram was constructed to summarize these associations. Receiver operating characteristic (ROC) analysis was performed to assess the degree of association between the PMT dimensions and vaccine hesitancy.

Among 1,492 participants (median age 53; 64.2% female), 80.5% of participants reported HZ vaccine hesitancy. Hesitancy was significantly associated with older age, peri-urban residence, employment and no history of HZ infection (p < .01). Among the PMT dimensions, lower Self-Efficacy (p=0.025), higher Response Costs (p < .001), and stronger Intrinsic Rewards (p = .002) and Extrinsic Rewards (p < .001) significantly contributed to hesitancy, while Response Efficacy (p = .230) showed no clear association. The adjusted multivariate logistic regression model had an area under the curve (AUC) of 0.788, with Self-Efficacy and Extrinsic Rewards showing notable individual contributions (AUC = 0.713 and 0.696, respectively).

HZ vaccine hesitancy is shaped by psychological and contextual factors. Public health strategies should prioritize perceived rewards, self-efficacy, and response costs. The tools developed in this study may guide targeted interventions in primary care. Future research should validate them across populations and assess their predictive utility in real-world settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY
CiteScore
7.90
自引率
8.30%
发文量
489
审稿时长
3-6 weeks
期刊介绍: (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信